← Back to Search

ABCS Training for Cardiovascular Risk in HIV/AIDS (ABCSinHIV Trial)

N/A

Waitlist Available

Led By Kevin Fiscella, MD, MPH

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 40-79 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

ABCSinHIV Trial Summary

This trial will develop and test strategies to increase the use of evidence-based interventions for heart disease among people living with HIV.

Who is the study for?

This trial is for HIV patients aged 40-79 at certain sites with a moderate risk of heart disease, who speak English or Spanish, and have texting capabilities. Clinicians treating these patients must be willing to try new strategies. Excluded are those with past heart events, vascular diseases, pregnancy, inability to consent, or involvement in another CVD trial.Check my eligibility

What is being tested?

The study tests the implementation of ABCS training (aspirin use, blood pressure control, cholesterol management, smoking cessation) to reduce cardiovascular risks in people living with HIV. It aims to improve the adoption of evidence-based interventions through this strategy.See study design

What are the potential side effects?

Since this trial focuses on implementing a training strategy rather than a medical intervention like medication or surgery, it does not directly involve side effects typically associated with clinical trials.

ABCSinHIV Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 40 and 79 years old.

ABCSinHIV Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

10-year CVD risk reduction

ABCSinHIV Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TrainingExperimental Treatment1 Intervention

CVD risk after the patient and clinician training

Group II: ControlActive Control1 Intervention

CVD risk prior to the patient and clinician training

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,834 Previous Clinical Trials

47,306,358 Total Patients Enrolled

University of RochesterLead Sponsor

836 Previous Clinical Trials

513,816 Total Patients Enrolled

Clinical Directors NetworkNETWORK

12 Previous Clinical Trials

9,969 Total Patients Enrolled

Media Library

ABCS training Clinical Trial Eligibility Overview. Trial Name: NCT03902431 — N/A

HIV/AIDS Research Study Groups: Control, Training

HIV/AIDS Clinical Trial 2023: ABCS training Highlights & Side Effects. Trial Name: NCT03902431 — N/A

ABCS training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03902431 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively seeking participants?

"According to clinicaltrials.gov, this particular medical trial is not actively searching for participants as the most recent information was added on November 8th 2022. Nevertheless, there are 320 other ongoing studies presently recruiting patients."

Answered by AI

Are individuals aged 40 or above qualified to partake in this trial?

"Prospective participants must comply with the age parameters outlined in this trial's eligibility criteria, which stipulate a minimum of 40 years old and an upper limit of 79."

Answered by AI

What demographic is most suited to this trial's conditions?

"All applicants for this clinical trial must be aged between 40 and 79, with a confirmed diagnosis of HIV. A total of 507 patients are being accepted across the study's sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Translating the ABCS Into HIV Care

Kevin Fiscella 2019. "Translating the ABCS Into HIV Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03902431.